Nifty
:
24213.30
Sensex
:
79476.63
217.95 (0.91%)
694.39 (0.88%)
Nifty
Sensex
:
:
24213.30
79476.63
217.95 (0.91%)
694.39 (0.88%)

Gennex Laboratories Ltd.

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 531739 | NSE: Not Listed

NSE BSE
20.6
05-Nov-2024
  • Open
  • High
  • Low
  • Previous Close
  •  20.01
  •  21
  •  20.01
  •  20.41
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  607823
  •  12547492
  •  29.00
  •  11.45

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 468.54
  • 30.98
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 413.29
  • N/A
  • 2.74

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 18.42%
  • 15.56%
  • 59.00%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 7.02%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.41
  • 3.29
  • 3.22

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.88
  • 3.13
  • -6.41

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 36.04
  • 17.25
  • 6.79

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 28.60
  • 27.88
  • 28.48

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.87
  • 2.00
  • 2.24

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.06
  • 17.99
  • 21.46

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Net Sales
28.32
16.49
71.74%
33.50
0.00
0
21.40
14.62
46.37%
18.18
19.62
-7.34%
Expenses
24.09
11.42
110.95%
29.26
0.00
0
16.60
12.80
29.69%
12.41
17.77
-30.16%
EBITDA
4.23
5.07
-16.57%
4.25
0.00
0
4.80
1.82
163.74%
5.77
1.85
211.89%
EBIDTM
14.93%
30.73%
12.68%
0.00%
22.42%
12.45%
31.74%
9.44%
Other Income
2.46
0.03
8,100.00%
2.02
0.00
0
0.00
0.00
0
0.00
0.00
0
Interest
0.73
0.73
0.00%
0.73
0.00
0
0.83
0.18
361.11%
0.78
0.36
116.67%
Depreciation
0.45
0.65
-30.77%
0.23
0.00
0
0.45
0.19
136.84%
1.03
0.10
930.00%
PBT
5.51
3.72
48.12%
5.30
0.00
0
3.51
1.45
142.07%
3.95
1.40
182.14%
Tax
0.85
0.87
-2.30%
0.81
0.00
0
0.75
0.37
102.70%
0.89
0.35
154.29%
PAT
4.66
2.85
63.51%
4.50
0.00
0
2.76
1.08
155.56%
3.06
1.05
191.43%
PATM
16.45%
17.28%
13.42%
0.00%
12.92%
7.42%
16.86%
5.34%
EPS
0.20
0.16
25.00%
0.20
0.00
0
0.16
0.07
128.57%
0.17
0.08
112.50%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Net Sales
-
65.60
61.21
59.65
55.62
55.80
43.78
41.91
Net Sales Growth
-
7.17%
2.62%
7.25%
-0.32%
27.46%
4.46%
 
Cost Of Goods Sold
-
39.91
38.10
35.72
33.62
32.70
26.73
23.93
Gross Profit
-
25.69
23.11
23.93
22.00
23.11
17.05
17.98
GP Margin
-
39.16%
37.76%
40.12%
39.55%
41.42%
38.94%
42.90%
Total Expenditure
-
60.91
55.84
53.12
52.37
51.78
41.59
37.38
Power & Fuel Cost
-
4.39
3.17
3.01
3.30
2.85
2.26
1.97
% Of Sales
-
6.69%
5.18%
5.05%
5.93%
5.11%
5.16%
4.70%
Employee Cost
-
7.87
6.97
7.21
6.81
6.12
5.55
4.96
% Of Sales
-
12.00%
11.39%
12.09%
12.24%
10.97%
12.68%
11.83%
Manufacturing Exp.
-
3.80
3.19
3.15
4.82
5.24
3.50
2.84
% Of Sales
-
5.79%
5.21%
5.28%
8.67%
9.39%
7.99%
6.78%
General & Admin Exp.
-
1.78
1.21
1.02
1.57
1.91
1.50
1.85
% Of Sales
-
2.71%
1.98%
1.71%
2.82%
3.42%
3.43%
4.41%
Selling & Distn. Exp.
-
2.53
2.13
2.40
1.69
2.26
1.49
1.23
% Of Sales
-
3.86%
3.48%
4.02%
3.04%
4.05%
3.40%
2.93%
Miscellaneous Exp.
-
0.62
1.06
0.61
0.56
0.69
0.57
0.60
% Of Sales
-
0.95%
1.73%
1.02%
1.01%
1.24%
1.30%
1.43%
EBITDA
-
4.69
5.37
6.53
3.25
4.02
2.19
4.53
EBITDA Margin
-
7.15%
8.77%
10.95%
5.84%
7.20%
5.00%
10.81%
Other Income
-
3.95
1.38
0.52
0.95
0.78
0.90
0.12
Interest
-
1.35
0.88
0.74
0.75
0.79
0.73
0.71
Depreciation
-
0.92
0.79
0.88
1.00
0.98
0.92
0.84
PBT
-
6.37
5.09
5.43
2.44
3.03
1.44
3.10
Tax
-
1.45
1.17
1.02
0.69
0.81
0.62
0.40
Tax Rate
-
22.76%
22.99%
20.16%
27.06%
26.73%
42.76%
12.90%
PAT
-
4.92
3.92
4.04
1.86
2.22
0.84
2.70
PAT before Minority Interest
-
4.92
3.92
4.04
1.86
2.22
0.84
2.70
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
7.50%
6.40%
6.77%
3.34%
3.98%
1.92%
6.44%
PAT Growth
-
25.51%
-2.97%
117.20%
-16.22%
164.29%
-68.89%
 
EPS
-
0.22
0.17
0.18
0.08
0.10
0.04
0.12

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Shareholder's Funds
80.35
43.82
39.71
35.67
33.82
31.77
30.94
Share Capital
18.02
12.65
12.65
12.65
12.65
12.65
12.65
Total Reserves
62.33
31.16
27.06
23.02
21.16
19.12
18.29
Non-Current Liabilities
16.15
0.00
0.17
0.41
0.62
1.04
1.13
Secured Loans
16.29
0.00
0.00
0.00
0.00
0.35
0.09
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.08
0.10
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Liabilities
29.51
24.21
19.02
20.86
17.30
17.66
17.14
Trade Payables
7.08
7.74
5.94
8.13
8.15
12.16
9.46
Other Current Liabilities
17.39
3.63
3.29
5.33
3.15
2.92
3.43
Short Term Borrowings
1.05
10.12
7.36
4.98
4.54
2.12
3.75
Short Term Provisions
3.99
2.71
2.43
2.42
1.46
0.45
0.50
Total Liabilities
132.18
68.03
58.90
56.94
51.74
50.47
49.21
Net Block
73.73
13.70
14.13
14.93
15.64
15.58
15.51
Gross Block
91.29
30.61
30.34
30.26
29.97
28.93
27.99
Accumulated Depreciation
17.56
16.92
16.22
15.33
14.33
13.35
12.49
Non Current Assets
83.50
20.84
22.52
21.98
22.69
22.80
22.97
Capital Work in Progress
0.02
0.00
0.00
0.00
0.00
0.00
0.23
Non Current Investment
0.01
6.83
6.83
6.83
6.83
7.00
7.01
Long Term Loans & Adv.
0.65
0.32
1.57
0.22
0.22
0.22
0.22
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
48.68
47.18
36.38
34.97
29.04
27.66
26.24
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
15.69
7.74
5.02
7.44
5.33
2.34
2.89
Sundry Debtors
9.42
11.31
7.66
6.28
10.40
10.46
10.30
Cash & Bank
15.06
8.31
1.07
0.91
3.15
1.02
0.63
Other Current Assets
8.50
0.60
1.16
2.06
10.18
13.84
12.42
Short Term Loans & Adv.
7.50
19.22
21.47
18.28
7.68
10.73
11.28
Net Current Assets
19.17
22.97
17.36
14.11
11.74
10.00
9.10
Total Assets
132.18
68.02
58.90
56.95
51.73
50.46
49.21

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Cash From Operating Activity
23.68
11.91
-1.44
-1.67
1.88
3.16
-0.11
PBT
6.37
5.28
5.06
2.55
3.03
1.45
3.10
Adjustment
-0.39
2.57
1.57
1.68
1.73
1.56
1.52
Changes in Working Capital
17.69
5.18
-6.54
-5.90
-2.53
1.16
-4.03
Cash after chg. in Working capital
23.68
13.02
0.10
-1.67
2.23
4.17
0.59
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
0.00
-1.11
-1.53
0.00
-0.35
-1.01
-0.70
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-38.33
-2.47
-0.02
-0.22
-0.99
-0.67
-0.97
Net Fixed Assets
-2.01
-0.27
-0.08
-0.29
-1.04
-0.71
Net Investments
-1.25
0.00
0.00
0.00
0.00
0.00
Others
-35.07
-2.20
0.06
0.07
0.05
0.04
Cash from Financing Activity
21.03
-1.83
1.62
-0.35
1.25
-2.10
0.86
Net Cash Inflow / Outflow
6.38
7.61
0.16
-2.23
2.13
0.39
-0.22
Opening Cash & Equivalents
8.68
1.07
0.91
3.15
1.02
0.63
0.85
Closing Cash & Equivalent
15.06
8.68
1.07
0.91
3.15
1.02
0.63

Financial Ratios

Standalone /

Consolidated
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Book Value (Rs.)
4.53
3.30
2.99
2.82
2.67
2.51
2.45
ROA
4.92%
6.18%
6.97%
3.42%
4.35%
1.68%
5.50%
ROE
7.95%
9.39%
10.71%
5.34%
6.77%
2.67%
8.74%
ROCE
10.19%
11.82%
13.24%
8.36%
10.52%
6.31%
10.91%
Fixed Asset Turnover
1.18
2.14
2.10
1.99
2.04
1.66
1.55
Receivable days
52.65
53.05
39.96
50.76
63.48
80.13
86.42
Inventory Days
59.51
35.67
35.71
38.85
23.33
20.19
24.26
Payable days
67.75
65.55
71.92
88.41
71.54
98.37
99.73
Cash Conversion Cycle
44.40
23.17
3.75
1.21
15.27
1.94
10.95
Total Debt/Equity
0.22
0.23
0.19
0.14
0.13
0.08
0.13
Interest Cover
5.71
6.80
7.81
4.38
4.81
2.99
5.40

Annual Reports:

FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015

News Update:


  • Gennex Lab - Quarterly Results
    14th Aug 2024, 17:27 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.